The new release in ACCP’s popular Pharmacotherapy Self-Assessment Program (PSAP) focuses on evidence-based management strategies for disease states affecting the endocrine and renal systems. An additional chapter relates the interpretation of clinical trial design and biostatistics to pharmacy practice and patient outcomes.

Endocrinology/Nephrology contains three learning modules with a total available 15.0 continuing pharmacy education (CPE) credits. The book content was developed under the leadership of Faculty Panel Chair Julie M. Sease, Pharm.D., FCCP, BCPS, BCACP, CDE.

Chapters in the first module review new evidence on the management of gestational diabetes, as well as new pharmacotherapies for type 2 diabetes. The second module explores hypothyroidism as well as adrenal disorders such as adrenal insufficiency, Cushing syndrome, and hyperaldosteronism. The third module includes chapters on acute renal failure and dialysis, nephrolithiasis, and clinical trial design and biostatistics.

Each PSAP release comes in two full-color online formats: (1) interactive PDFs you can save to your desktop or print; and (2) an e-media version you can view on an e-reader, tablet, iOS or Android smart phone. Each release also includes the popular PSAP Audio Companion, audio MP3 files that can be downloaded to a player or burned onto a CD. A one-color softbound print book is available for an added fee.

All PSAP chapters are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

• Release date: January 17, 2017
• BCPS credit expiration date: May 15, 2017
• ACPE credit expiration date: January 14, 2020